Sunshine Biopharma Inc (NASDAQ:SBFM)’s traded shares stood at 4.55 million during the last session, with the company’s beta value hitting -1.09. At the close of trading, the stock’s price was $3.80, to imply a decrease of -44.12% or -$3.0 in intraday trading. The SBFM share’s 52-week high remains $140.00, putting it -3584.21% down since that peak but still an impressive -15.53% since price per share fell to its 52-week low of $4.39. The company has a valuation of $377.91M, with an average of 237.08K shares over the past 3 months.

Sunshine Biopharma Inc (NASDAQ:SBFM) trade information

After registering a -44.12% downside in the last session, Sunshine Biopharma Inc (SBFM) has traded red over the past five days. The stock hit a weekly high of 10.0000, dropping -44.12% in its intraday price action. The 5-day price performance for the stock is -61.26%, and -28.97% over 30 days. With these gigs, the year-to-date price performance is -86.00%.

Sunshine Biopharma Inc (SBFM) estimates and forecasts

The rating firms project that company’s revenue will grow 84.30% compared to the previous financial year.

Revenue forecast for the current quarter as set by 1 analysts is $7 million. Meanwhile, for the quarter ending Jun 2024, a total of 1 analyst(s) estimate revenue growth to $9 million.Earnings reports from the last fiscal year show that sales brought in -$ and -$ respectively in the corresponding quarters.

SBFM Dividends

Sunshine Biopharma Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Sunshine Biopharma Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.